Earnings Summary

Bioventus Inc’s revenue fell -2.32% since last year same period to $137.07Mn in the Q2 2023. On a quarterly growth basis, Bioventus Inc has generated 15.13% jump in its revenue since last 3-months.

Bioventus Inc’s net profit jumped 49.24% since last year same period to $-3.68Mn in the Q2 2023. On a quarterly growth basis, Bioventus Inc has generated 97.35% jump in its net profits since last 3-months.

Bioventus Inc’s net profit margin jumped 48.03% since last year same period to -2.69% in the Q2 2023. On a quarterly growth basis, Bioventus Inc has generated 97.7% jump in its net profit margins since last 3-months.

Bioventus Inc’s earning per share (EPS) estimates for the current quarter stand at 0.04 - a -66.67% fall from last quarter’s estimates.

Bioventus Inc’s earning per share (EPS) estimates for the current year stand at 0.04.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Bioventus Inc’s return on assets (ROA) stands at -0.02.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Bioventus Inc’s return on equity (ROE) stands at -0.79.